• 1
    Ghendon Y. Influenza surveillance. Bull WHO 1991; 69: 50915.
  • 2
    Matter H. Annual report of the Swiss Sentinel Surveillance Network. Berne: Swiss Federal Office of Public Health, 1998: 4352.
  • 3
    Chappuis S, Paccaud MF, Wunderli W. Surveillance of influenza in Switzerland between 1987 and 1995. Schweiz Med Wochenschr 1996; 126: 113542.
  • 4
    Kraft M, Heckler R, Klepp J, Metzger C, Steinbiss J, Wunderli W. Multicenter evaluation of a new influenza A/B rapid test. In: Program and Abstracts of the 3rd Annual Meeting of ESCV, Budapest, Hungary. Budapest: European Society for Clinical Virology, 1999: 85.
  • 5
    Hindiey M, Goulding C, Morgan H et al. Evaluation of BioStar® assay for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Virol 2000; 17: 11926.
  • 6
    Schultze D, Thomas Y, Wunderli W. Evaluation of an optical immunoassay for the rapid detection of influenza A and B viral antigens. Eur J Clin Microbiol Infect Dis 2001; 20: 2803.
  • 7
    Covlcivc KA, Webb KH, Carlon CA. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA Test) and cell culture method. J Clin Microbiol 1999; 37: 39714.
  • 8
    Hermann B, Larsson C, Zweyberg BW. Simultaneous detection and typing of influenza A and B by nested reverse transcription-PCR. Comparison to virus isolation, optical immunoassay (FLU OIA). J Clin Microbiol 2001; 39: 1348.
  • 9
    Kaiser L, Briones MS, Hayden FG. Performance of virus isolation and Directigen® Flu A to detect influenza A virus in experimental human infection. J Clin Virol 1999; 14: 1917.